Goldman Sachs Sees Positive Outlook for Immunome with $26 Price Target - Timothy Sykes

Retrieved on: 2025-09-29 09:26:10

Tags for this article:

Click the tags to see associated articles and topics

Goldman Sachs Sees Positive Outlook for Immunome with $26 Price Target - Timothy Sykes. View article details on hiswai:

Excerpt

... s stocks have been trading up by 15.2 percent. Key Highlights Elevating Immunome's Prospects Goldman Sachs initiates coverage on Immunome ...

Article found on: www.timothysykes.com